Recent international studies have significantly changed the understanding of Post-Tuberculosis Lung Disease (PTLD). Experts now recognize that curing tuberculosis does not always mean the lungs have completely healed. Millions of TB survivors continue to experience chronic respiratory symptoms due to permanent lung damage. One of the commonest long-term consequences is Bronchiectasis after TB, a condition where the airways become permanently widened, inflamed, and prone to recurrent infections. (ERS Publications)
Key findings from recent literature include:
- Around 155 million TB survivors are estimated to be living worldwide.
- Nearly 60% of patients with Post-TB Lung Disease show abnormal lung function.
- Bronchiectasis is among the most frequent structural complications after pulmonary tuberculosis.
- Indian bronchiectasis registries report that India has one of the highest proportions of post-TB bronchiectasis worldwide, with tuberculosis accounting for up to 35.5% of bronchiectasis cases in some datasets. (CHEST Physician)
These findings make Bronchiectasis After TB an increasingly important health topic, particularly in countries like India where TB remains common.
What Is Bronchiectasis?
Imagine your lungs as an upside-down tree. The windpipe forms the trunk, while the airways branch repeatedly into smaller and smaller tubes, finally ending in tiny air sacs where oxygen enters your bloodstream. In a healthy person, these airways are smooth, elastic, and capable of clearing mucus naturally through microscopic hair-like structures called cilia. Every breath you take depends on this remarkable cleaning system working efficiently. When tuberculosis infects the lungs, however, this delicate architecture can be permanently altered.
Bronchiectasis is a chronic lung disease characterized by irreversible widening and destruction of the bronchial airways. Unlike asthma or pneumonia, where inflammation may improve completely with treatment, bronchiectasis represents permanent structural damage. The enlarged airways become inefficient at clearing mucus, allowing secretions to accumulate. This stagnant mucus becomes an ideal environment for bacteria, leading to repeated infections, persistent inflammation, and a vicious cycle of further airway damage. Patients often experience chronic cough, daily sputum production, recurrent chest infections, breathlessness, and occasionally life-threatening coughing of blood (hemoptysis).
In India, previous tuberculosis remains one of the leading causes of bronchiectasis, unlike many Western countries where genetic disorders or childhood infections are more common causes. Recent registry data indicate that post-TB bronchiectasis accounts for a substantial proportion of bronchiectasis cases in high TB burden countries. This explains why many individuals who have successfully completed anti-tubercular therapy continue to struggle with respiratory symptoms months or even years later. The infection may be cured, but the structural damage can persist, requiring long-term specialized care. (JBP)
How Does Tuberculosis Damage the Lungs?
Tuberculosis is not simply another bacterial infection. It is an aggressive disease caused by Mycobacterium tuberculosis, capable of triggering an intense immune response that often harms healthy lung tissue while trying to eliminate the bacteria. During active pulmonary TB, inflammatory cells surround infected areas, leading to tissue destruction, cavity formation, and necrosis. Although anti-TB medications successfully eradicate the bacteria in most patients, the healing process frequently replaces normal lung tissue with scar tissue rather than restoring healthy architecture. This is why many patients continue to experience respiratory problems despite being declared microbiologically cured.
The damage extends beyond the lung tissue itself. Tuberculosis can destroy the walls of bronchi, weaken cartilage supporting the airways, and interfere with the normal mucociliary clearance mechanism. As these airway walls lose their structural integrity, they gradually dilate and become permanently distorted. Fibrosis surrounding these bronchi further pulls them open, producing what radiologists describe as “traction bronchiectasis.” These widened airways are unable to clear mucus effectively, creating ideal conditions for recurrent bacterial colonization. Organisms such as Pseudomonas aeruginosa are particularly common in patients with advanced post-TB bronchiectasis and contribute significantly to repeated exacerbations. (Tuberktoraks)
Another important consequence is the development of Post-Tuberculosis Lung Disease (PTLD), now recognized as a distinct clinical entity by international respiratory societies. PTLD encompasses fibrosis, bronchiectasis, chronic airflow obstruction, destroyed lung syndrome, pleural thickening, pulmonary hypertension, and reduced exercise capacity. Studies show that approximately one-third of TB survivors develop clinically significant PTLD, while spirometry abnormalities are observed in nearly 60% of patients. This growing body of evidence highlights the need for long-term follow-up even after successful completion of TB treatment. (PMC)
Why Does Bronchiectasis Develop After TB?
One of the most common questions patients ask is, “If my TB is cured, why am I still coughing?” The answer lies in understanding that curing the infection does not automatically reverse the structural damage already inflicted on the lungs. Tuberculosis can permanently injure the airway walls, and unlike skin or liver tissue, the lungs have only a limited capacity to regenerate complex bronchial structures. Once these airways become permanently widened, they remain vulnerable to mucus retention and recurrent infections.
This ongoing cycle can be explained simply. Damaged airways retain mucus. Retained mucus encourages bacterial growth. Infection leads to inflammation. Inflammation causes further destruction of airway walls. The newly damaged airways trap even more mucus, perpetuating the cycle. Without proper management—including airway clearance techniques, vaccinations, pulmonary rehabilitation, appropriate antibiotics, and specialist follow-up—patients may experience progressive lung function decline over many years.
Another important factor is the location of the disease. Tuberculosis often affects the upper lobes of the lungs, and bronchiectasis developing in these regions may remain localized for years. However, severe or recurrent infections can eventually spread inflammation to adjacent lung segments. Some patients also develop associated complications such as chronic pulmonary aspergillosis, recurrent massive hemoptysis, fibrothorax, or a completely destroyed lung. In carefully selected patients with localized disease causing repeated infections or significant bleeding, minimally invasive thoracic surgery (VATS or robotic surgery) may offer definitive treatment and substantially improve quality of life. Modern surgical techniques allow removal of the diseased portion of the lung while preserving as much healthy lung tissue as possible whenever feasible. (CHEST Physician)
Symptoms of Bronchiectasis After TB
One of the biggest misconceptions surrounding tuberculosis is that once the six-month course of medication is complete, the lungs return to normal. Unfortunately, that is not always the case. Many patients visit the clinic months or even years after successful TB treatment complaining of a persistent cough, repeated chest infections, or breathlessness. These symptoms are often dismissed as “old TB changes” until a high-resolution CT (HRCT) scan reveals bronchiectasis. Recognizing these symptoms early is crucial because timely treatment can significantly reduce infections, preserve lung function, and improve quality of life.
The hallmark symptom of post-TB bronchiectasis is a chronic productive cough. Unlike the dry cough seen in many viral infections, this cough usually produces sputum every day. The sputum may be white, yellow, green, or occasionally foul-smelling if bacterial infection is present. Many patients notice that they cough more after waking up because mucus accumulates overnight and is cleared when they change position. During exacerbations, sputum volume often increases dramatically and may become thicker or blood-stained.
Another common complaint is shortness of breath, particularly while climbing stairs, walking uphill, or carrying groceries. Breathlessness develops because damaged airways cannot efficiently move air into and out of the lungs. Repeated infections and progressive scarring further reduce the amount of healthy lung available for oxygen exchange. Patients often describe this as feeling like they “never regained full breathing capacity” after TB treatment. Fatigue, reduced exercise tolerance, and decreased productivity frequently accompany this symptom, affecting work, social life, and emotional well-being.
Perhaps the most alarming symptom is hemoptysis, or coughing up blood. Small streaks of blood mixed with sputum may occur after forceful coughing, but larger amounts should never be ignored. Bronchiectatic airways contain fragile, enlarged blood vessels that can rupture during infection or inflammation. In severe cases, massive hemoptysis becomes a life-threatening emergency requiring immediate hospitalization. Patients with recurrent bleeding should be evaluated by an experienced thoracic surgeon because surgical removal of the diseased lung segment or lobe may provide a permanent solution when the disease is localized.
Other symptoms that patients commonly experience include:
- Persistent productive cough lasting months or years
- Daily sputum production
- Recurrent fever during infections
- Breathlessness on exertion
- Wheezing or noisy breathing
- Chest discomfort
- Fatigue
- Weight loss during frequent infections
- Bad breath due to chronic infection
- Recurrent coughing up blood
These symptoms tend to fluctuate. Many patients feel relatively well between infections but experience repeated “flare-ups” requiring antibiotics several times each year. Recognizing this recurring pattern is often the first clue that permanent airway disease rather than active tuberculosis is responsible.
Who Is at Risk of Developing Bronchiectasis After TB?
Not every patient who recovers from pulmonary tuberculosis develops bronchiectasis. Some individuals heal with minimal residual damage, while others are left with permanent structural changes that continue to cause symptoms for decades. Researchers have identified several factors that increase the likelihood of developing post-tuberculosis bronchiectasis, allowing doctors to identify high-risk patients who require closer follow-up.
One of the strongest predictors is extensive pulmonary tuberculosis at the time of diagnosis. Patients who had large cavities, bilateral disease, delayed diagnosis, or severe destruction visible on chest imaging are more likely to develop permanent airway damage. Tuberculosis causes inflammation that destroys bronchial cartilage and supporting tissues. The larger the area affected during the active infection, the greater the risk that irreversible bronchiectasis will develop during healing. Patients who required prolonged hospitalization or had advanced disease before treatment are therefore particularly vulnerable.
Another important risk factor is delayed initiation of anti-tubercular therapy. Tuberculosis continues to damage the lungs until effective treatment begins. Individuals who experience months of symptoms before diagnosis accumulate greater tissue destruction compared with patients diagnosed early. This highlights why persistent cough lasting more than two weeks should always be investigated promptly, particularly in countries where TB remains common. Early diagnosis not only improves cure rates but also reduces long-term disability caused by permanent lung damage.
Certain patients also have an increased risk because of underlying medical conditions. Diabetes mellitus, HIV infection, chronic malnutrition, smoking, chronic obstructive pulmonary disease (COPD), and immune suppression can impair healing after tuberculosis. Continued smoking after TB treatment is especially harmful because cigarette smoke further damages airway lining, impairs mucus clearance, and accelerates progression of bronchiectasis. Even passive smoking can contribute to ongoing airway inflammation.
Repeated chest infections after completion of TB treatment represent another warning sign. Each infection triggers additional inflammation that further damages already weakened airways. Patients caught in this cycle often report needing antibiotics several times every year. Without comprehensive management—including airway clearance, vaccination, pulmonary rehabilitation, and specialist follow-up—the disease may slowly progress over time.
Patients should seek specialist evaluation if they have:
| Risk Factor | Why It Matters |
| Previous cavitary TB | Greater airway destruction |
| Delayed TB diagnosis | Longer period of lung damage |
| Recurrent chest infections | Progressive airway injury |
| Smoking | Reduced mucus clearance |
| Diabetes | Poor healing and immunity |
| HIV or immunosuppression | Increased infection risk |
| Persistent productive cough after TB | Possible underlying bronchiectasis |
| Recurrent hemoptysis | May indicate severe localized disease |
Early identification allows doctors to intervene before irreversible decline in lung function occurs.
Diagnosis of Bronchiectasis After TB
Diagnosing bronchiectasis involves much more than simply ordering a chest X-ray. While conventional X-rays may show old scarring from tuberculosis, they often underestimate the true extent of airway damage. Modern diagnosis relies on combining clinical history, advanced imaging, microbiological testing, and lung function assessment to understand both the severity of disease and the best treatment strategy for each individual patient.
High-Resolution CT (HRCT) Chest
The HRCT chest is considered the gold standard for diagnosing bronchiectasis. It provides detailed images of the airways that cannot be appreciated on routine chest X-rays. Radiologists look for permanently widened bronchi, thickened airway walls, mucus plugging, destroyed lung segments, fibrosis, cavities, and traction bronchiectasis. HRCT also identifies whether the disease is localized to one lobe or diffusely involves both lungs, an important distinction when considering surgery.
In post-TB bronchiectasis, HRCT often demonstrates upper lobe predominance because tuberculosis most commonly affects these regions. The scan may also reveal calcified lymph nodes, residual cavities, pleural thickening, or associated fungal balls (aspergilloma), all of which influence treatment decisions. For surgeons, HRCT serves as a roadmap, helping determine whether diseased lung tissue can be safely removed while preserving adequate healthy lung.
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests evaluate how well the lungs are functioning rather than simply how they look. Spirometry measures airflow obstruction, while diffusion studies estimate the lungs’ ability to transfer oxygen into the bloodstream. These tests establish a baseline before treatment and help monitor disease progression over time.
Many patients with post-TB bronchiectasis demonstrate obstructive airflow limitation similar to COPD, while others show restrictive impairment due to fibrosis. Some exhibit a mixed pattern. Knowing the exact physiology guides inhaler therapy, pulmonary rehabilitation, and surgical planning. Patients being considered for lung resection require careful preoperative lung function assessment to ensure adequate respiratory reserve after surgery.
Sputum Culture and Microbiological Testing
Not every chest infection requires the same antibiotic. One of the biggest advances in bronchiectasis care has been the routine use of sputum cultures to identify the bacteria responsible for recurrent infections. Common organisms include Pseudomonas aeruginosa, Haemophilus influenzae, Klebsiella species, and occasionally non-tuberculous mycobacteria. Identifying the exact organism allows doctors to prescribe targeted antibiotics rather than relying on broad-spectrum drugs that contribute to antibiotic resistance.
It is equally important to distinguish recurrent bacterial infection from recurrent tuberculosis. Patients who develop new symptoms after previous TB treatment should undergo sputum examination for acid-fast bacilli, molecular testing where indicated, and fungal evaluation if clinically suspected. Chronic pulmonary aspergillosis, particularly aspergilloma developing within old TB cavities, is a well-recognized complication that may present with recurrent hemoptysis and require specialized treatment, including surgery in selected patients.
Bronchoscopy may also be recommended in selected situations, especially when persistent bleeding, airway obstruction, or suspicion of another underlying disease exists. By combining HRCT findings, lung function tests, microbiological results, and clinical assessment, physicians can create a personalized treatment plan aimed at controlling infections, preserving lung function, and improving long-term quality of life.
Treatment of Bronchiectasis After TB
One of the first questions patients ask after being diagnosed with post-TB bronchiectasis is, “Can this condition be cured?” The answer requires understanding the difference between reversing damage and controlling disease. The damaged airways cannot return to their original normal structure because bronchiectasis is permanent. However, modern treatment can dramatically reduce symptoms, prevent recurrent infections, improve exercise capacity, preserve lung function, and significantly enhance quality of life. Many patients who receive comprehensive care are able to return to work, travel, and enjoy an active lifestyle with far fewer hospital admissions.
Successful treatment is never based on a single medicine. Instead, it involves a combination of infection control, airway clearance, vaccination, pulmonary rehabilitation, nutritional optimization, smoking cessation, and, in carefully selected patients, surgery. Recent European Respiratory Society (ERS) and British Thoracic Society (BTS) guidelines emphasize an individualized approach because no two bronchiectasis patients are exactly alike. Factors such as the extent of lung involvement, frequency of infections, sputum microbiology, lung function, and presence of complications all influence treatment decisions.
Patients should also understand that bronchiectasis management is proactive rather than reactive. Waiting until severe infections occur allows further airway damage to accumulate. Regular follow-up with a pulmonologist and thoracic surgeon helps detect deterioration early, adjust treatment plans, and prevent avoidable complications. The goal is not simply to treat infections but to break the vicious cycle of mucus retention, bacterial colonization, inflammation, and progressive airway destruction.
Airway Clearance Therapy: The Cornerstone of Treatment
If there is one treatment that every patient with bronchiectasis should understand, it is airway clearance therapy. Think of the damaged airways as clogged drainage pipes. Antibiotics may kill bacteria, but unless the mucus is physically removed, bacteria quickly return. Clearing secretions every day is therefore one of the most effective ways to reduce infections and preserve lung function.
Airway clearance techniques are usually taught by experienced respiratory physiotherapists. These include Active Cycle of Breathing Techniques (ACBT), postural drainage, autogenic drainage, positive expiratory pressure (PEP) devices, oscillatory devices such as the Flutter or Acapella, and breathing exercises designed to mobilize mucus from smaller airways. Regular physical activity, brisk walking, swimming, and supervised pulmonary rehabilitation further enhance mucus clearance by improving ventilation and respiratory muscle strength.
Hydration is equally important. Well-hydrated mucus is thinner and easier to cough out than thick, sticky secretions. Some patients benefit from nebulized hypertonic saline or other mucolytic therapies that improve sputum clearance, although treatment should always be individualized. Daily airway clearance often becomes a lifelong habit, but patients who remain consistent frequently report fewer infections, reduced cough, and better quality of life.
Medications Used in Bronchiectasis After TB
Medication therapy depends on the patient’s symptoms and microbiological profile. Antibiotics remain the cornerstone during acute exacerbations. Whenever possible, treatment should be guided by sputum culture results rather than empirical antibiotic use. Culture-directed therapy improves bacterial eradication while reducing antibiotic resistance.
Some patients with frequent exacerbations may benefit from long-term macrolide therapy, such as azithromycin, after appropriate evaluation. Clinical trials have shown that prolonged macrolide treatment can significantly reduce exacerbation frequency in carefully selected patients. However, these medications require monitoring because of potential side effects including hearing impairment, cardiac rhythm disturbances, and development of resistant organisms.
Bronchodilator inhalers may help patients with associated airflow obstruction, particularly if asthma or COPD coexists. Inhaled corticosteroids are not routinely recommended for bronchiectasis alone but may be indicated when there is concurrent asthma or eosinophilic airway disease. Vaccinations against influenza, pneumococcus, COVID-19, and other preventable respiratory infections are strongly encouraged because every infection has the potential to accelerate lung damage.
Pulmonary Rehabilitation and Lifestyle Changes
Many patients believe that exercise should be avoided because they become breathless. The opposite is true. Carefully supervised pulmonary rehabilitation is one of the most effective non-pharmacological treatments available. These structured programs combine aerobic exercise, strength training, breathing exercises, nutritional advice, and education about disease management. Studies consistently demonstrate improvements in exercise capacity, breathlessness, fatigue, and overall quality of life.
Nutrition also plays a surprisingly important role. Recurrent infections increase the body’s metabolic demands, while chronic coughing may reduce appetite. Patients should consume adequate protein to preserve muscle mass and maintain a healthy body weight. Those who are underweight often experience poorer outcomes, whereas obesity may worsen breathlessness and exercise intolerance. Consultation with a dietitian can be valuable, particularly for patients with advanced disease.
Lifestyle modifications include complete smoking cessation, avoidance of passive smoke exposure, minimizing indoor air pollution, maintaining excellent oral hygiene, and prompt treatment of respiratory infections. Adequate sleep, vaccination, and regular medical follow-up further contribute to long-term disease control. These seemingly simple measures collectively reduce the frequency of exacerbations and help preserve remaining healthy lung tissue.
When Is Surgery Needed for Bronchiectasis After TB?
Although most patients respond well to medical therapy, surgery remains an extremely important treatment option for selected individuals. Contrary to common belief, lung surgery is not reserved only for cancer. Carefully chosen patients with localized bronchiectasis often experience dramatic improvement after removal of the diseased portion of the lung. The challenge lies in selecting the right patient at the right time.
Surgery is usually considered when bronchiectasis is confined to one lobe or segment and causes persistent symptoms despite optimal medical treatment. Common indications include recurrent infections requiring repeated hospitalization, chronic productive cough that severely affects quality of life, recurrent or massive hemoptysis, destroyed lung syndrome, localized aspergilloma, persistent abscess formation, or bronchiectasis complicated by drug-resistant bacterial colonization. Removing the chronically infected lung tissue eliminates the source of repeated infections while preserving the healthier portions of the lung.
Modern thoracic surgery has evolved tremendously over the past two decades. Whenever feasible, Video-Assisted Thoracoscopic Surgery (VATS) or robotic thoracic surgery allows lung resection through small incisions rather than the large thoracotomy incision traditionally used. Benefits include reduced postoperative pain, faster recovery, shorter hospital stay, earlier return to work, and improved cosmetic outcomes. However, patients with previous tuberculosis often have dense adhesions and calcified lymph nodes, making these operations technically demanding. Such procedures should therefore be performed by surgeons with extensive experience in complex thoracic surgery and post-TB lung disease.
Comparison of Surgical Approaches
| Feature | VATS Surgery For Bronchiectasis after TB | Open Thoracotomy For Bronchiectasis after TB |
| Incision | Small (2–4 cm ports) | Large chest incision |
| Pain | Less | More |
| Hospital stay | 3–5 days | 6–10 days |
| Recovery | Faster | Longer |
| Blood loss | Usually lower | Usually higher |
| Cosmetic result | Better | Larger scar |
| Suitable for | Most localized disease | Complex adhesions or extensive disease |
Even when surgery is recommended, it is never undertaken lightly. Every patient undergoes detailed HRCT imaging, pulmonary function testing, cardiac assessment, sputum evaluation, and multidisciplinary discussion to ensure the expected benefits outweigh the risks.
Can Bronchiectasis After TB Be Completely Cured?
Patients frequently hope that antibiotics or surgery will permanently eliminate bronchiectasis. The reality is more nuanced. The damaged airways themselves cannot regenerate, so bronchiectasis is considered irreversible. However, that does not mean patients are destined to progressive disability. With modern multidisciplinary care, many individuals live active, productive lives while experiencing only occasional symptoms.
For patients whose disease is diffuse and affects both lungs, treatment focuses on controlling infection, improving mucus clearance, preserving lung function, and preventing exacerbations. These patients require long-term follow-up but often remain stable for many years when they adhere to treatment. Education plays a vital role because recognizing early signs of infection allows prompt treatment before severe deterioration occurs.
Patients with localized disease have an additional advantage. When all diseased lung tissue can be safely removed, surgery may effectively eliminate the source of recurrent infection or bleeding. Although surgery does not “cure” bronchiectasis elsewhere in the lungs, carefully selected patients often describe it as life-changing because chronic cough, repeated antibiotic use, and recurrent hospital admissions are dramatically reduced.
Why Choose Dr. Kamran Ali for Bronchiectasis Surgery in India?
Bronchiectasis following tuberculosis presents unique surgical challenges. Previous TB often causes dense pleural adhesions, calcified lymph nodes, distorted anatomy, and chronic inflammation that increase operative complexity. Successful outcomes therefore depend not only on surgical skill but also on careful patient selection, meticulous preoperative planning, and comprehensive postoperative care.
Dr. Kamran Ali, Associate Director of Thoracic Surgery at Max Super Speciality Hospital, Saket, New Delhi, specializes exclusively in thoracic diseases. His practice includes minimally invasive VATS, uniportal VATS, and robotic thoracic surgery for complex benign and malignant lung conditions. He has extensive experience managing post-TB lung disease, including bronchiectasis, destroyed lung syndrome, aspergilloma, chronic empyema, and massive hemoptysis. Every patient undergoes individualized evaluation to determine whether continued medical management or surgery offers the best long-term outcome.
For international and Indian patients alike, a multidisciplinary team approach involving thoracic surgeons, pulmonologists, respiratory physiotherapists, anesthesiologists, infectious disease specialists, and intensive care physicians ensures comprehensive treatment tailored to each patient’s specific needs.
Conclusion
Completing tuberculosis treatment is an important milestone, but it is not always the end of the journey. Many survivors continue to experience chronic cough, recurrent chest infections, breathlessness, or hemoptysis because of bronchiectasis after TB. Fortunately, advances in respiratory medicine and thoracic surgery now provide effective ways to control symptoms, reduce infections, preserve lung function, and improve quality of life.
Early diagnosis using HRCT, regular follow-up, airway clearance therapy, culture-guided antibiotics, pulmonary rehabilitation, vaccination, and healthy lifestyle choices form the foundation of treatment. Patients with localized disease causing repeated infections or significant bleeding should not assume lifelong medical therapy is their only option. Modern minimally invasive thoracic surgery can offer definitive treatment in carefully selected cases, helping patients regain confidence and return to normal life.
If you continue to experience cough, sputum production, breathlessness, or coughing up blood after completing TB treatment, seek evaluation from a thoracic specialist. Early intervention can prevent further lung damage and open the door to treatments that may significantly improve your long-term health.
Frequently Asked Questions (FAQs)
1. Can bronchiectasis develop years after TB?
Yes. Many patients remain symptom-free for years before recurrent infections or chronic cough reveal underlying post-TB bronchiectasis.
2. Is bronchiectasis contagious?
No. Bronchiectasis itself is not contagious. However, active tuberculosis or certain respiratory infections may be infectious and require appropriate evaluation.
3. Can exercise improve bronchiectasis after TB?
Yes. Pulmonary rehabilitation and regular exercise improve fitness, mucus clearance, breathing efficiency, and overall quality of life.
4. Will every patient with bronchiectasis require surgery?
No. Most patients are treated successfully with medications and airway clearance. Surgery is reserved for carefully selected patients with localized disease or complications such as recurrent hemoptysis.
5. What is the best investigation for bronchiectasis?
A High-Resolution CT (HRCT) scan of the chest is the gold standard for diagnosing bronchiectasis and determining its severity.
References
- European Respiratory Society. Post-Tuberculosis Lung Disease: Current Understanding and Management. https://publications.ersnet.org/content/breathe/22/1/250243
- British Thoracic Society Guideline for Bronchiectasis in Adults. https://thorax.bmj.com/content/74/Suppl_1
- European Respiratory Society Bronchiectasis Guidelines. https://erj.ersjournals.com
- Journal Brasileiro de Pneumologia. Post-Tuberculosis Bronchiectasis. https://jbp.org.br
- National Institute for Health and Care Excellence (NICE): Bronchiectasis. https://www.nice.org.uk
- World Health Organization. Tuberculosis Fact Sheets. https://www.who.int/teams/global-tuberculosis-programme
- Chest Physician. The Burden of Post-Tuberculosis Lung Disease. https://www.chestphysician.org/the-burden-of-post-tb-lung-disease/
Related Articles:
- Post Tuberculosis Lung Damage: Understanding Life After TB
- Surgery for Destroyed Lung
- Destroyed Lung After TB
- Massive Hemoptysis After TB
- Aspergilloma After TB
- Trapped Lung After TB
- Post-TB Fibrosis
- When Is Surgery Needed After TB?
- Living With One Destroyed Lung
Author
Dr. Kamran Ali
Associate Director – Thoracic Surgery
Max Super Speciality Hospital, Saket, New Delhi
Dr. Kamran Ali specializes in minimally invasive thoracic surgery (VATS and Robotic Surgery), lung cancer surgery, surgery for post-tuberculous lung diseases, bronchiectasis, aspergilloma, empyema, airway surgery, and lung transplantation. He regularly manages complex cases of Bronchiectasis after tuberculosis, offering advanced bronchoscopic evaluation, multidisciplinary treatment planning, and definitive surgical management when required.
Medical Disclaimer:
This article is intended for educational purposes only and should not replace professional medical advice. Early diagnosis and treatment by an experienced pulmonologist and thoracic surgeon can be life-saving.
